State Street Corp Grows Holdings in OmniAb, Inc. (NASDAQ:OABI)

State Street Corp lifted its stake in shares of OmniAb, Inc. (NASDAQ:OABI) by 1.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,031,676 shares of the company’s stock after buying an additional 34,654 shares during the quarter. State Street Corp owned approximately 1.72% of OmniAb worth $8,594,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Palumbo Wealth Management LLC lifted its holdings in OmniAb by 12.5% during the 3rd quarter. Palumbo Wealth Management LLC now owns 24,640 shares of the company’s stock worth $104,000 after buying an additional 2,744 shares during the last quarter. Sei Investments Co. raised its position in shares of OmniAb by 11.0% during the 2nd quarter. Sei Investments Co. now owns 29,024 shares of the company’s stock valued at $109,000 after acquiring an additional 2,888 shares in the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in OmniAb by 64.5% during the third quarter. China Universal Asset Management Co. Ltd. now owns 22,727 shares of the company’s stock worth $96,000 after purchasing an additional 8,909 shares during the last quarter. CWC Advisors LLC. acquired a new stake in shares of OmniAb during the third quarter worth $54,000. Finally, FMR LLC lifted its position in shares of OmniAb by 10.6% in the 3rd quarter. FMR LLC now owns 138,813 shares of the company’s stock worth $587,000 after buying an additional 13,324 shares during the last quarter. Institutional investors own 72.08% of the company’s stock.

Analyst Ratings Changes

OABI has been the topic of several research reports. Benchmark reiterated a “buy” rating and set a $8.00 price objective on shares of OmniAb in a research note on Thursday, November 14th. HC Wainwright reiterated a “buy” rating and set a $11.00 price target on shares of OmniAb in a research report on Thursday, November 14th.

OmniAb Stock Up 0.6 %

OABI stock opened at $3.59 on Friday. The stock has a market cap of $506.97 million, a PE ratio of -5.79 and a beta of -0.14. The firm’s 50-day simple moving average is $3.95 and its 200 day simple moving average is $4.13. OmniAb, Inc. has a fifty-two week low of $3.43 and a fifty-two week high of $6.72.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.